Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.
about
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease.Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementiaClinicopathological outcomes of prospectively followed normal elderly brain bank volunteers.Tau accumulation in the nucleus accumbens in tangle-predominant dementiaTOC1: a valuable tool in assessing disease progression in the rTg4510 mouse model of tauopathy.Neural Correlates of Verbal Episodic Memory and Lexical Retrieval in Logopenic Variant Primary Progressive Aphasia.Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities.TDP-43 is a key player in the clinical features associated with Alzheimer's diseasePrimary age-related tauopathy (PART): a common pathology associated with human agingPART, a distinct tauopathy, different from classical sporadic Alzheimer disease.Quantitative neuropathological assessment to investigate cerebral multi-morbidity.Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.A depressive endophenotype of mild cognitive impairment and Alzheimer's diseaseClinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.Differential clinicopathologic and genetic features of late-onset amnestic dementiasChildhood Learning Disabilities and Atypical Dementia: A Retrospective Chart ReviewEarly Life Epidemiology of Alzheimer's Disease--A Critical ReviewAn autoradiographic evaluation of AV-1451 Tau PET in dementia.MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodiesRegional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.The role of cholesterol metabolism in Alzheimer's disease.Challenges of multimorbidity of the aging brain: a critical update.Invited review: Neuropathology of tauopathies: principles and practice.Case Studies Illustrating Focal Alzheimer's, Fluent Aphasia, Late-Onset Memory Loss, and Rapid Dementia.Pathology of Neurodegenerative Diseases.Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's diseaseAlzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.A depressive endophenotype of poorer cognition among cognitively healthy community-dwelling adults: results from the Western Australia memory study.In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.Molecular subtypes of Alzheimer's disease.Characterization of brain anatomical patterns by comparing region intensity distributions: Applications to the description of Alzheimer's disease.Dementia in the oldest old
P2860
Q30008912-678581E9-532D-4A99-AF5E-EA33FE9B9B73Q30576502-D9569977-3E86-4DEA-A085-6C223C323438Q33456273-FB6AFC1A-6971-4113-A2F0-B39B0D56C0ECQ33622415-7C01731B-4DD4-4C87-8BE0-1D81B7B2DC9EQ33749435-B03596E0-7B48-40A6-953B-C56005839D04Q33794460-8E314FCD-69ED-4560-A064-2A690FFE1C57Q34139476-BAF0ECB3-1D12-4C6E-9E35-FAE24240F577Q34232167-C4914E79-F93C-49B2-A534-B98D7712E420Q34445021-C6E6C065-6234-4AC4-BAE9-197F71428EEAQ34467464-0AC86F1A-1034-4217-A90F-14A21A1C662BQ34584768-6C942D3B-357F-4D8F-AF3A-6DD33B8A4C42Q34614543-ADB5F7C6-EB01-4FE6-B5A6-BE81613E651CQ34851404-43A30C27-CD2F-47DC-980A-0F305727DD4FQ35529715-51EA319F-B231-4D63-B227-306A52078EC0Q35545502-98726433-C483-4E8D-96B7-1737064A229EQ35672676-CD57BB23-8655-4088-AE26-158F0E078504Q36373380-869C092A-768E-418F-B9F0-4FEC7ED3D756Q37001820-85BCAA46-302E-45D6-A5A8-C7292B0040D4Q37265436-8248DA70-CAE2-420C-BD88-4ED88B6D0AC5Q37723422-EA870593-C9CB-4F8F-9DAA-8E82C6C0E7CEQ38212604-D8A50FF4-42D2-42D5-83C1-35D62745AC47Q38236878-DC373968-3478-4950-9C1C-5719ADEDD7FDQ38286208-BB2F6A48-9A98-4584-A01E-922E7BA15AD3Q38389822-D272E394-F2F5-442D-8AD9-31B6A61E8033Q39071493-4C37EFC6-BDA6-4AB3-A186-46446874DB23Q42689688-5C494EF0-D882-437E-93F0-814EED855AFBQ47588927-76FF4D8D-8620-4847-83BB-AB02D5E158B4Q47666324-B2F10DAE-5BE7-4236-8B1F-3BC758FCC9DCQ48176222-0246F06F-C90A-4110-833E-6FB986958D25Q48447490-93F38BC3-F965-4B11-887C-754986625999Q49831229-6CF7C734-8290-4C6F-A287-BFAE9652601CQ53829181-45CA7C93-D04E-4A66-83C3-799C4B0349C4Q57724897-039F795E-3133-4466-8211-D615A89128F8
P2860
Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Neuropathologically defined su ...... y tangle-predominant dementia.
@ast
Neuropathologically defined su ...... y tangle-predominant dementia.
@en
type
label
Neuropathologically defined su ...... y tangle-predominant dementia.
@ast
Neuropathologically defined su ...... y tangle-predominant dementia.
@en
prefLabel
Neuropathologically defined su ...... y tangle-predominant dementia.
@ast
Neuropathologically defined su ...... y tangle-predominant dementia.
@en
P2093
P2860
P50
P1476
Neuropathologically defined su ...... y tangle-predominant dementia.
@en
P2093
Alexandra I Soto-Ortolaza
Amanda M Liesinger
Kevin A Brodersen
Neill R Graff-Radford
Nicholas J Janocko
Ranjan Duara
P2860
P2888
P304
P356
10.1007/S00401-012-1044-Y
P577
2012-09-12T00:00:00Z